CD33 and Alzheimer disease: CD33 regulation of TREM2 surface expression is specifically mediated by membrane-bound CD33; individuals with the CD33 AD risk variant have increased surface TREM2 expression, an effect which was abrogated with a CD33 neutralizing antibody which downregulates surface CD33 [8].